Albania vs Ethiopia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Albania
81.0%
in 2025
Ethiopia
81.0%
in 2025
Albania rank
113th
Ethiopia rank
113th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Albania
- Ethiopia
How they compare
Albania currently reports 81.0% against 81.0% in Ethiopia, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Ethiopia ahead.
Albania ranks 113th and Ethiopia ranks 113th of 194 countries.
Albania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Albania | Ethiopia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 88.8% | 46.4% | 42.4% | Albania |
| 2020s | 85.8% | 73.7% | 12.2% | Albania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Albania or Ethiopia?
- Albania, at 81.0% against 81.0% in Ethiopia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Albania and Ethiopia?
- 0.0%, with Albania ahead.
- How many years of comparable data are there for Albania and Ethiopia?
- 18 years are reported by both, from 2008 to 2025.
- How do Albania and Ethiopia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Albania ranks 113th and Ethiopia ranks 113th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.